T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma	Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, astrocytoma (excluding glioblastoma), epithelial neoplasm, glioblastoma, glioma, neoplasm, neuroepithelial neoplasm, primitive neuroectodermal tumor	Active, not recruiting	Phase 1 / Phase 2	2026-06-26		NCT06157541

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Austin Hospital, Melbourne Australia	4
CUREator	1
Merck Sharp & Dohme LLC	650
Princess Alexandra Hospital, Brisbane, Australia	9
Queensland Institute of Medical Research	2
Royal Brisbane and Women's Hospital	8
The Newro Foundation	1

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Austin Hospital	Heidelberg	Australia	37
Newro Foundation	Bowen Hills	Australia	1
Princess Alexandra Hospital	Woolloongabba	Australia	106
Royal Brisbane and Women's Hospital	Herston	Australia	12